Cargando…
Natural products: potential drugs for the treatment of renal fibrosis
With the increasing prevalence and mortality, chronic kidney disease (CKD) has become a world public health problem. As the primary pathological manifestation in CKD, renal fibrosis is often used as a critical target for the treatment of CKD and inhibits the progression of CKD to end-stage renal dis...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386947/ https://www.ncbi.nlm.nih.gov/pubmed/35978370 http://dx.doi.org/10.1186/s13020-022-00646-z |
_version_ | 1784769921932066816 |
---|---|
author | Zhou, Zijun Qiao, Yanheng Zhao, Yanru Chen, Xin Li, Jie Zhang, Hanqing Lan, Qiumei Yang, Bo |
author_facet | Zhou, Zijun Qiao, Yanheng Zhao, Yanru Chen, Xin Li, Jie Zhang, Hanqing Lan, Qiumei Yang, Bo |
author_sort | Zhou, Zijun |
collection | PubMed |
description | With the increasing prevalence and mortality, chronic kidney disease (CKD) has become a world public health problem. As the primary pathological manifestation in CKD, renal fibrosis is often used as a critical target for the treatment of CKD and inhibits the progression of CKD to end-stage renal disease (ESRD). As a potential drug, natural products have been confirmed to have the potential as a routine or supplementary therapy for chronic kidney disease, which may target renal fibrosis and act through various pharmacological activities such as anti-inflammatory and anti-oxidation of natural products. This article briefly introduces the pathological mechanism of renal fibrosis and systematically summarizes the latest research on the treatment of renal fibrosis with natural products of Chinese herbal medicines. |
format | Online Article Text |
id | pubmed-9386947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93869472022-08-19 Natural products: potential drugs for the treatment of renal fibrosis Zhou, Zijun Qiao, Yanheng Zhao, Yanru Chen, Xin Li, Jie Zhang, Hanqing Lan, Qiumei Yang, Bo Chin Med Review With the increasing prevalence and mortality, chronic kidney disease (CKD) has become a world public health problem. As the primary pathological manifestation in CKD, renal fibrosis is often used as a critical target for the treatment of CKD and inhibits the progression of CKD to end-stage renal disease (ESRD). As a potential drug, natural products have been confirmed to have the potential as a routine or supplementary therapy for chronic kidney disease, which may target renal fibrosis and act through various pharmacological activities such as anti-inflammatory and anti-oxidation of natural products. This article briefly introduces the pathological mechanism of renal fibrosis and systematically summarizes the latest research on the treatment of renal fibrosis with natural products of Chinese herbal medicines. BioMed Central 2022-08-17 /pmc/articles/PMC9386947/ /pubmed/35978370 http://dx.doi.org/10.1186/s13020-022-00646-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Zhou, Zijun Qiao, Yanheng Zhao, Yanru Chen, Xin Li, Jie Zhang, Hanqing Lan, Qiumei Yang, Bo Natural products: potential drugs for the treatment of renal fibrosis |
title | Natural products: potential drugs for the treatment of renal fibrosis |
title_full | Natural products: potential drugs for the treatment of renal fibrosis |
title_fullStr | Natural products: potential drugs for the treatment of renal fibrosis |
title_full_unstemmed | Natural products: potential drugs for the treatment of renal fibrosis |
title_short | Natural products: potential drugs for the treatment of renal fibrosis |
title_sort | natural products: potential drugs for the treatment of renal fibrosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386947/ https://www.ncbi.nlm.nih.gov/pubmed/35978370 http://dx.doi.org/10.1186/s13020-022-00646-z |
work_keys_str_mv | AT zhouzijun naturalproductspotentialdrugsforthetreatmentofrenalfibrosis AT qiaoyanheng naturalproductspotentialdrugsforthetreatmentofrenalfibrosis AT zhaoyanru naturalproductspotentialdrugsforthetreatmentofrenalfibrosis AT chenxin naturalproductspotentialdrugsforthetreatmentofrenalfibrosis AT lijie naturalproductspotentialdrugsforthetreatmentofrenalfibrosis AT zhanghanqing naturalproductspotentialdrugsforthetreatmentofrenalfibrosis AT lanqiumei naturalproductspotentialdrugsforthetreatmentofrenalfibrosis AT yangbo naturalproductspotentialdrugsforthetreatmentofrenalfibrosis |